Yaz, Yasmin and other newer birth control pills will soon be bearing warning labels that detail the potential risk of blood clot risks, the U.S. Food and Drug Administration (FDA) announced on Tuesday ...

Watson, Bayer in patent lawsuit over Yaz Yaz had U.S. sales of $173 mln for year ended Sept. 30 Nov 29 (Reuters) - Watson Pharmaceuticals Inc said it received U.S. regulatory approval for a generic ...

A new JAMA Network Open study highlights how over-the-counter oral contraceptives can reduce barriers to care, especially for ...

PARIS (Reuters) - French health authorities will ask the European Union to restrict the use of newer types of contraceptive pills over concerns they might carry health risks. France's health minister ...